// App-Quantinova.ai

5177 : RNAseq and FACS profiling of syngeneic mouse models treated with immune checkpoint inhibitors enable biomarker discovery and model selection for cancer immunotherapy

Researchers

Presenter

  • Lan Zhang

Principal Investigators

  • Juan Zhang

  • Sheng Guo

  • Wubin Qian

  • Zhensheng Wang

  • Qian Shi

Medical Centers

  • Crown Biosciences, Taicang, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Programmed death-ligand 1

  • Cytotoxic T-lymphocyte-associated protein 4

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved